Futura Medical plc (LON:FUM – Get Free Report) dropped 9.1% on Friday . The stock traded as low as GBX 8.50 ($0.11) and last traded at GBX 9.20 ($0.12). Approximately 729,276 shares traded hands during trading, an increase of 8% from the average daily volume of 672,447 shares. The stock had previously closed at GBX 10.13 ($0.13).
Futura Medical Stock Performance
The company has a fifty day moving average of GBX 13.78 and a two-hundred day moving average of GBX 26.75. The company has a market cap of £28.13 million, a PE ratio of -7.44 and a beta of 1.25.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Further Reading
- Five stocks we like better than Futura Medical
- What is a Low P/E Ratio and What Does it Tell Investors?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- 5 Top Rated Dividend Stocks to Consider
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- The Most Important Warren Buffett Stock for Investors: His Own
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
